REFERENCES
- Tatemoto K, Hosoya M, Habata Y, . Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun. 1998;251:471–476.
- O’Dowd BF, Heiber M, Chan A, . A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene. 1993;136:355–360.
- Medhurst AD, Jennings CA, Robbins MJ, . Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. J Neurochem. 2003; 84:1162–1172.
- O’Carrol AM, Selby TL, Palkovits M, Lolait SJ. Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues. Biochim Biophys Acta. 2000;1492:72–80.
- Soltani Hekmat A, Najafipour H, Nekooian AA, Esmaeli-Mahani S, Javanmardi K. Cardiovascular responses to apelin in two-kidney-one-clip hypertensive rats and its receptor expression in ischemic and non-ischemic kidneys. Regul Pept. 2011;172:62–68.
- Siddiquee K, Hampton J, Khan S, . Apelin protects against angiotensin II-induced cardiovascular fibrosis and decreases plasminogen activator inhibitor type-1 production. J Hypertens. 2011;29:724–731.
- Dray C, Knauf C, Daviaud D, . Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab. 2008;8:437–445.
- Yue P, Jin H, Aillaud M, . Apelin is necessary for the maintenance of insulin sensitivity. Am J Physiol Endocrinol Metab. 2010;298:E59–E67.
- Higuchi K, Masaki T, Gotoh K, . Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice. Endocrinology. 2007;148:2690–2697.
- Yue P, Jin H, Xu S, . Apelin decreases lipolysis via G(q), G(i), and AMPK-dependent mechanisms. Endocrinology. 2011;152:59–68.
- Daviaud D, Boucher J, Gesta S, . TNFα up-regulates apelin expression in human and mouse adipose tissue. FASEB J. 2006;20:E796–E802.
- García-Díaz D, Campión J, Milagro FI, Martínez JA. Adiposity dependent apelin gene expression: Relationships with oxidative and inflammation markers. Mol Cell Biochem. 2007;305:87–94.
- Hashimoto T, Kihara M, Imai N, . Requirement of apelin-apelin receptor system for oxidative-stress linked atherosclerosis. Am J Pathol. 2007;171:1705–1712.
- Melgar-Lesmes P, Pauta M, Reichenbach V, . Hypoxia and proinflammatory factors upregulate apelin receptor expression in human stellate cells and hepatocytes. Gut. 2011;60:1404–1411.
- Stenvinkel P. Inflammation in end-stage renal disease – a fire that burns within. Contrib Nephrol. 2005;149:185–199.
- Shastri S, Sarnak MJ. Cardiovascular disease and CKD: Core curriculum 2010. Am J Kidney Dis. 2010;56:399–417.
- Wratten ML, Galaris D, Tetta C, Sevanian A. Evolution of oxidative stress and inflammation during hemodialysis and their contribution to cardiovascular disease. Antioxid Redox Signal. 2002;4:935–944.
- Fouque D, Kalantar-Zadeh K, Kopple J, . A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73:391–398.
- Lohman TG, Roche AF, Martorell R eds. Anthropometric Standardization Reference Manual. Champaign, IL: Human Kinetics; 1991.
- Heymsfield SB, McManus C, Smith J, Stevens V, Nixon DW. Anthropometric measurement of muscle mass: Revised equations for calculating bone-free arm muscle area. Am J Clin Nutr. 1982;36:680–690.
- Frisancho AR. Anthropometric Standards for the Assessments of Growth and Nutritional Status. Ann Arbor, MI: University of Michigan; 1990:189 p.
- NCEP (National Cholesterol Education Program). Executive summary of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc. 2001;285:2486–2497.
- Valdez R. A simple model-based index of abdominal adiposity. J Clin Epidemiol. 1991;44:955–956.
- Lobo J, Santos F, Grosso D, . Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis. Nephron Clin Pract. 2008;108:298–304.
- Sargent J, Gotch F. Principles and biophysics of dialysis. In: Drukker W, Parsons F, Maher J, eds. Replacement of Renal Function by Dialysis. 2nd ed. The Hague: Martinues Nijhoff; 1985:53.
- Castan-Laurell I, Dray C, Attané C, Dupare T, Knauf C, Valet P. Apelin, diabetes, and obesity. Endocrine. 2011;40:1–9.
- Malyszko J, Kozminski P, Malszko J, Mysliwiec M. Type of arteriovenous fistula, NYHA class and apelin in hemodialyzed patients. Int Urol Nephrol. 2011;43:185–190.
- Malyszko J, Malyszko JS, Kozminski P, Mysliwiec M. Apelin and cardiac function in hemodialyzed patients: Possible relations? Am J Nephrol. 2006;26:121–126.
- El-Shehaby AM, El-Kathib MM, Battah AA, Roshdy AR. Apelin: A potential link between inflammation and cardiovascular disease in end stage renal disease patients. Scand J Clin Lab Invest. 2010;70:421–427.
- Codognotto M, Piccoli A, Zaninotto M, . Evidence for decreased circulating apelin beyond heart involvement in uremic cardiomyopathy. Am J Nephrol. 2007;27:1–6.
- Zhang DL, Liao H, Wei YY, Zhang Y, Zhang QD, Wang ZG. Elevation of serum apelin-13 is positively correlated with ADMA in patients on maintenance hemodialysis. Clin Nephrol. 2009;71:405–412.
- Malyszko J, Malyszko JS, Mysliwiec M. Visfatin and endothelial function in dialyzed patients. Nephrology. 2010;15:190–196.
- O’Shea M, Hansen MJ, Tatemoto K, Morris MJ. Inhibitory effect of apelin-12 on nocturnal food intake in the rat. Nutr Neurosci. 2003;6:163–167.
- Boucher J, Masri B, Daviaud D, . Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology. 2005;146:1764–1771.
- Tiani C, Garcia-Pras E, Mejias M, . Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats. J Hepatol. 2009;50:296–305.
- Han S, Wang G, Qi X, Lee HM, Englander EW, Greeley Jr, GH. A possible role for hypoxia-induced apelin expression in enteric cell proliferation. Am J Physiol Regul Integr Comp Physiol. 2008;294:R1832–R1839.
- Geiger K, Muendlein A, Stark N, . Hypoxia induces apelin expression in human adipocytes. Horm Metab Res. 2011;43: 380–385.
- Glassford AJ, Yue P, Sheikh AY, . HIF-1 regulates hypoxia- and insulin-induced expression of apelin in adipocytes. Am J Physiol Endocrinol Metab. 2007;293:E1590–E1596.
- Valle A, Hoggard N, Adams AC, Roca P, Speakman JR. Chronic central administration of apelin-13 over 10 days increases food intake, body weight, locomotor activity and body temperature in C57BL/6 mice. J Neuroendocrinol. 2008;20:79–84.
- Clarke KJ, Whitaker KW, Reyes TM. Diminished metabolic responses to centrally-administered apelin-13 in diet-induced obese rats fed a high-fat diet. J Neuroendocrinol. 2009;21:83–89.
- Hung WW, Hsieh TJ, Lin T, . Blockade of the renin-angiotensin system ameliorates apelin production in 3T3-L1 adipocytes. Cardiovasc Drugs Ther. 2011;25:3–12.
- Foussal C, Lairez O, Calise D, . Activation of catalase by apelin prevents oxidative stress-linked cardiac hypertrophy. FEBS Lett. 2010;584:2363–2370.
- Koken T, Serteser M, Kahraman A, Gokçe C, Demir S. Changes in serum markers of oxidative stress within various periods of hemodialysis. Nephrology. 2004;9:77–82.
- Vickers C, Hales P, Kaushik V, . Hydrolysis of biological peptides by human angiotensin-converting enzyme related carboxypeptidase. J Biol Chem. 2002;277:14838–14843.